Filter Results:
(1,460)
Show Results For
- All HBS Web
(6,515)
- Faculty Publications (1,460)
Show Results For
- All HBS Web
(6,515)
- Faculty Publications (1,460)
- April 2006
- Article
The Firm Specificity of Individual Performance: Evidence from Cardiac Surgery
By: Robert S. Huckman and Gary P. Pisano
Huckman, Robert S., and Gary P. Pisano. "The Firm Specificity of Individual Performance: Evidence from Cardiac Surgery." Management Science 52, no. 4 (April 2006): 473–488.
- Article
The Information Technology Ecosystem: Structure, Health, and Performance
By: Marco Iansiti and Gregory L. Richards
A number of modern industries are organized as complex networks of firms whose integrated efforts are necessary to deliver value to end customers. The complexity of these networks, or business ecosystems, and the associated interdependencies among firms, make... View Details
Keywords: Business Ventures; Networks; Value; Customers; Performance Productivity; Product; Applications and Software; Innovation and Invention; Competition; Business Model; Information Infrastructure; Information Technology Industry
Iansiti, Marco, and Gregory L. Richards. "The Information Technology Ecosystem: Structure, Health, and Performance." Antitrust Bulletin 51, no. 1 (Spring 2006).
- February 2006 (Revised February 2009)
- Case
AIDS in Brazil
By: Rohit Deshpande and Ricardo Reisen de Pinho
Abbott Labs has reached an impasse with the Brazilian government in negotiations over the pricing of a new anti-AIDS drug, Kaletra. The Brazilian government threatens compulsory licensing unless Abbott drastically reduces the price of Kaletra. View Details
Keywords: Price; Government and Politics; Health Care and Treatment; Health Disorders; Rights; Negotiation; Business and Government Relations; Pharmaceutical Industry; Brazil
Deshpande, Rohit, and Ricardo Reisen de Pinho. "AIDS in Brazil." Harvard Business School Case 506-062, February 2006. (Revised February 2009.)
- 2006
- Book
Confidence: How Winning Streaks and Losing Streaks Begin and End
Is success simply a matter of money and talent? Or is there another reason why some people and organizations always land on their feet, while others, equally talented, stumble again and again? There's a fundamental principle at work—confidence—that makes the difference... View Details
Keywords: Social Psychology
Kanter, Rosabeth M. Confidence: How Winning Streaks and Losing Streaks Begin and End. New York: Three Rivers Press, 2006. (Paperback edition with new Foreword, Epilogue, and Appendix.)
- January 2006 (Revised May 2007)
- Case
Endo Pharmaceuticals (A): From LBO to...?
By: Richard G. Hamermesh and Brian DeLacey
Endo Pharmaceuticals was formed in 1997 as a leveraged buyout spin-off from DuPont Merck. In 1999, it must decide whether to do an IPO or merge with a smaller company. View Details
Keywords: Private Equity; Initial Public Offering; Leveraged Buyouts; Mergers and Acquisitions; Health Care and Treatment; Pharmaceutical Industry; United States
Hamermesh, Richard G., and Brian DeLacey. "Endo Pharmaceuticals (A): From LBO to...?" Harvard Business School Case 806-064, January 2006. (Revised May 2007.)
- January 2006 (Revised April 2007)
- Case
General Electric Healthcare, 2006
By: Tarun Khanna and Elizabeth Raabe
In January 2006, Joe Hogan, head of General Electric (GE) Healthcare Technologies, prepared to step into William Castell's shoes as CEO of GE Healthcare, the world's leading manufacturer of diagnostic imaging equipment. In 2004, former CEO Jeff Immelt acquired Amersham... View Details
Keywords: Corporate Entrepreneurship; Cost vs Benefits; Growth and Development Strategy; Mergers and Acquisitions; Machinery and Machining; Global Range; Multinational Firms and Management; Product Design; Technological Innovation; Expansion; Value Creation; Business Subsidiaries; Health Industry; Health Industry
Khanna, Tarun, and Elizabeth Raabe. "General Electric Healthcare, 2006." Harvard Business School Case 706-478, January 2006. (Revised April 2007.)
- 2006
- Chapter
Consumer-Driven Healthcare: Transforming the Delivery of Health Services
By: R. E. Herzlinger
Herzlinger, R. E. "Consumer-Driven Healthcare: Transforming the Delivery of Health Services." In Futurescan: Healthcare Trends and Implications, 2006 2011, 13–20. Health Administration Press, 2006.
- 2006
- Case
Empowering Nurses at University College London Hospitals
By: Julie Battilana, A.-M., Cagna, T., D'Aunno and M.J., Gilmartin
- 2006
- Case
In Reach Care of the Elderly: Moss Valley Medical Practice
By: Julie Battilana, A. M. Cagna and T. D'Aunno
- 2006
- Case
Redesigning a Stroke Service: Developing Collaboration across Organizations
By: Julie Battilana, A.M., Cagna, T., D'Aunno and M.J., Gilmartin
- December 2005 (Revised October 2013)
- Case
Fred Khosravi and AccessClosure (A)
By: Richard Hamermesh and Liz Kind
Fred Khosravi is a serial medical device entrepreneur. In his latest venture, he must decide whether to sell now or continue to develop his current product and whether to market it, sell the company, or IPO. View Details
Keywords: Negotiation; Medical Devices; Venture Capital; Life Sciences; Health Care Industry; Healthcare Technology; Healthcare Ventures; Business Startups; Decision Choices and Conditions; Entrepreneurship; Growth and Development Strategy; Medical Devices and Supplies Industry; United States
Hamermesh, Richard, and Liz Kind. "Fred Khosravi and AccessClosure (A)." Harvard Business School Case 806-044, December 2005. (Revised October 2013.)
- December 2005 (Revised April 2010)
- Teaching Note
Leerink Swann & Co.: Creating Competitive Advantage (TN)
By: Boris Groysberg and Andrew N. McLean
- December 2005 (Revised August 2006)
- Case
Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug
By: Felix Oberholzer-Gee and Dennis A. Yao
Amgen Inc.'s Epogen was the first biotech blockbuster drug. Epogen helped prevent anemia, a condition that leads to severe fatigue, increased risk of cardiovascular disease, and even death. At the time, the market for Epogen, which included dialysis patients and... View Details
Keywords: Health Care and Treatment; Strategic Planning; Competition; Patents; Innovation and Invention; Pharmaceutical Industry; Biotechnology Industry; United States
Oberholzer-Gee, Felix, and Dennis A. Yao. "Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug." Harvard Business School Case 706-454, December 2005. (Revised August 2006.)
- November 2005 (Revised December 2005)
- Case
County Department of Public Health: Organizing for Emergency Preparedness and Response
By: Lynda M. Applegate, Ajay Vinze and Minu Ipe
The anthrax attacks of 2001 exposed serious inadequacies in the response of the U.S. public health system to meet such grave threats. The public health infrastructure required rebuilding to respond to any type of large-scale health emergency. The Public Health... View Details
Keywords: Information Technology; Change Management; Crisis Management; Health Care and Treatment; Infrastructure; Health Industry; Health Industry; United States
Applegate, Lynda M., Ajay Vinze, and Minu Ipe. "County Department of Public Health: Organizing for Emergency Preparedness and Response." Harvard Business School Case 806-089, November 2005. (Revised December 2005.)
- November 2005 (Revised November 2005)
- Case
Massachusetts General Hospital and the Enbrel Royalty
By: David S. Scharfstein and Darren R. Smart
Massachusetts General Hospital is considering selling its royalty interest in Enbrel, Amgen's blockbuster drug for the treatment of rheumatoid arthritis. In assessing whether to sell, and at what price, the hospital must determine its value to a potential buyer as well... View Details
Keywords: Valuation; Price; Investment Return; Capital; Value; Revenue; Health Care and Treatment; Health Industry; Health Industry; Massachusetts
Scharfstein, David S., and Darren R. Smart. "Massachusetts General Hospital and the Enbrel Royalty." Harvard Business School Case 206-075, November 2005. (Revised November 2005.)
- November 2005 (Revised November 2011)
- Background Note
Entrepreneurship and Venture Capital in Healthcare Fall Term 2011: Course Outline and Syllabus
By: Richard G. Hamermesh and Robert F. Higgins
Provides an overview of the second-year MBA elective course Entrepreneurship and Venture Capital in Healthcare. View Details
Hamermesh, Richard G., and Robert F. Higgins. "Entrepreneurship and Venture Capital in Healthcare Fall Term 2011: Course Outline and Syllabus." Harvard Business School Background Note 806-048, November 2005. (Revised November 2011.)
- October 2005 (Revised September 2006)
- Case
DentalCorp
By: Richard G. Hamermesh and Ricardo Reisen de Pinho
DentalCorp is the fifth largest provider of dental insurance in Brazil and has tripled its sales in the past two years. Whether to expand to Chile or to continue expansion in Brazil is the major strategic choice facing the company at the end of 2004. View Details
Keywords: International Finance; Expansion; Entrepreneurship; Health Care and Treatment; Global Strategy; Health Industry; Health Industry; Brazil; Chile
Hamermesh, Richard G., and Ricardo Reisen de Pinho. "DentalCorp." Harvard Business School Case 806-023, October 2005. (Revised September 2006.)
- October 2005 (Revised June 2007)
- Case
Apollo Hospitals--First-World Health Care at Emerging-Market Prices
By: Felix Oberholzer-Gee, Tarun Khanna and Carin-Isabel Knoop
The Apollo Hospitals Group, one of Asia's premier health care organizations, had come to rival the best health care organizations on the globe. Apollo offered advanced medical procedures, such as cardiac surgery using the beating heart technique, at very high levels of... View Details
Keywords: Vertical Integration; Decision Choices and Conditions; Health Care and Treatment; Global Strategy; Developing Countries and Economies; Health Industry; Thailand; United States; India
Oberholzer-Gee, Felix, Tarun Khanna, and Carin-Isabel Knoop. "Apollo Hospitals--First-World Health Care at Emerging-Market Prices." Harvard Business School Case 706-440, October 2005. (Revised June 2007.)
- August 2005 (Revised December 2006)
- Case
Procter & Gamble: Electronic Data Capture and Clinical Trial Management
By: Robert S. Huckman and Mark J. Cotteleer
Considers whether the management of Procter & Gamble (P&G) Pharmaceuticals should adopt Web-based electronic data capture (EDC) as the default standard for the management of its clinical drug trials. Provides a detailed description of the existing paper-based process... View Details
Keywords: Health Testing and Trials; Internet and the Web; Information Technology; Adoption; Business Processes; Industry Structures; Technological Innovation; Service Operations; Pharmaceutical Industry; United States
Huckman, Robert S., and Mark J. Cotteleer. "Procter & Gamble: Electronic Data Capture and Clinical Trial Management." Harvard Business School Case 606-033, August 2005. (Revised December 2006.)